IBE
print

Sprachumschaltung

Navigationspfad


Inhaltsbereich
Selda Ugur

Selda Ugur

Arbeitsbereiche

Early Stage Researcher at Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein

Kontakt

Dermatologie am Biederstein,
Biedersteiner Str. 29,
80802 Munich


Project Title

MELIUS - Improving the care situation for allergy sufferers in the event of changing environmental conditions in the context of climate change (based on Crowdsourcing-Data)

Research Interests

• Crowdsourcing-Data
• Digital Medicine
• Dermatology
• Public Health
• Epidemiology
• Health Service Research

Supervisor(s)

Prof. Dr. Dr. med. Alexander Zink

Curriculum Vitae

EDUCATION

since 10/2024 - PhD candidate Medical Research in EPH

• 2017 - 2020: Master of Science in Biology at LMU (Munich)
• 2013 - 2017: Bachelor of Science in Biology at LMU (Munich)

 WORK EXPERIENCE

• 2021 - 2024: Medical Information Associate/Medical Advisor D-A-CH (Bencard Allergie)
• 2019 - 2020: Internship at Marketing Department/Cardiovascular Diseases (Amgen)

 Publications

Klauer LK, Schutti O, Ugur S, Doraneh-Gard F, Amberger DC, Rogers N, Krämer D, Rank A, Schmid C, Eiz-Vesper B, Schmetzer HM. Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe LeukaemiaDerived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro. Transfus Med Hemother. 2021

Plett C, Klauer LK, Amberger DC, Ugur S, Rabe A, Fischer Z, Deen D, Hirn-Lopez A, Gunsilius C, Werner JO, Schmohl J, Krämer D, Rank A, Schmid C, Schmetzer HM. Immunomodulatory kits generating leukaemia derived dendritic cells do not induce blast proliferation ex vivo: IPO-38 as a novel marker to quantify proliferating blasts in acute myeloid leukaemia. Clin Immunol. 2022

Rackl E, Li L, Klauer LK, Ugur S, Pepeldjiyska E, Seidel CL, Gunsilius C, Weinmann M, Doraneh-Gard F, Reiter N, Plett C, Amberger DC, Bojko P, Kraemer D, Schmohl J, Rank A, Schmid C, Schmetzer HM. Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes. Int J Mol Sci. 2022

Rackl E, Hartz A, Aslan Rejeski H, Li L, Klauer LK, Ugur S, Pepeldjiyska E, Amend C, Weinmann M, Doraneh-Gard F, Stein J, Reiter N, Seidel CL, Plett C, Amberger DC, Bojko P, Kraemer D, Schmohl J, Rank A, Schmid C, Schmetzer HM. Dendritic/antigen presenting cell mediated provision of T-cell receptor gamma delta (TCRγδ) expressing cells contributes to improving antileukemic reactions ex vivo. Mol Immunol. 2024